<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04620876</url>
  </required_header>
  <id_info>
    <org_study_id>P16-02</org_study_id>
    <secondary_id>2016-A00704-47</secondary_id>
    <nct_id>NCT04620876</nct_id>
  </id_info>
  <brief_title>Bimodal and Coaxial High Resolution Ophtalmic Imaging</brief_title>
  <acronym>AOSLO-OCT</acronym>
  <official_title>Bimodal and Coaxial High Resolution Ophtalmic Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The knowledge of the pathogenesis of retinal affections, a major cause of blindness, has&#xD;
      greatly benefited from recent advances in retinal imaging. However, optical aberrations of&#xD;
      the ocular media limit the resolution that can be achieved by current techniques.&#xD;
&#xD;
      The use of an adaptive optics system improves the resolution of ophthalmoscopes by several&#xD;
      orders of magnitude, allowing the visualization of many retinal microstructures:&#xD;
      photoreceptors, vessels, bundles of nerve fibers.&#xD;
&#xD;
      Recently, the development of the coupling of the two main imaging techniques, the Adaptive&#xD;
      Optics Ophthalmoscope with Optical Coherence Tomography, enables unparalleled&#xD;
      three-dimensional in vivo cell-scale imaging, while remaining comfortable for the patients.&#xD;
&#xD;
      The purpose of this project is to evaluate the performance of this system for imaging&#xD;
      micrometric retinal structures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of the project is the capture and analysis of images with AOSLO system, in order to&#xD;
      evaluate the performance of this system compared to OCT imaging devices and existing Adaptive&#xD;
      Optics used at National Hospital of Ophthalmology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">October 15, 2024</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visualization and image analysis of a structure of interest</measure>
    <time_frame>From date of inclusion until the date of last documented progression , assessed up to 5 years</time_frame>
    <description>The visualization of the structure of interest in at least one area of the image will be considered the main criterion of success.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Retinitis Pigmentosa</condition>
  <condition>Maculopathy, Age Related</condition>
  <condition>Macular Dystrophy</condition>
  <condition>Macular Edema</condition>
  <condition>Retinal Detachment</condition>
  <condition>Retinal Degeneration</condition>
  <condition>Glaucoma</condition>
  <condition>Vascular Inflammation</condition>
  <condition>Hypertension</condition>
  <condition>Stroke</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Bimodal and coaxial high resolution imaging of the retina</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optical coherence tomography and Scanning laser ophthalmoscope system using adaptive optics (AO-SLO-OCT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bimodal high resolution imaging of the retina</intervention_name>
    <description>The protocol consists of performing an Optical coherence tomography and Scanning laser ophthalmoscope system using adaptive optics (AO-SLO-OCT).The participant is asked to put his forehead against the temple supports and his chin on a chin rest. The subject will be asked to fix a test pattern in the form of a cross. The pattern is positioned according to the desired eccentricity with respect to the fovea. The actual acquisition lasts a few seconds, possibly repeated to cover the field of the desired eye. The acquisition protocol depends on the subjects, their pathology and the system used; the area examined will be modified on a case by case basis. The total duration of each exam can be estimated at less than half an hour, with frequent breaks.</description>
    <arm_group_label>Bimodal and coaxial high resolution imaging of the retina</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  People over 18&#xD;
&#xD;
          -  Patient with a pathology affecting the eye or healthy volunteer&#xD;
&#xD;
          -  Participant who signed the consent&#xD;
&#xD;
          -  Beneficiaries of the health insurance&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Patients with a history of photosensitivity.&#xD;
&#xD;
          -  Patients who have just received a photodynamic therapy treatment&#xD;
&#xD;
          -  Patients taking drugs with photosensitivity as a side effect.&#xD;
&#xD;
          -  Persons with pacemakers or other implanted electronic medical device&#xD;
&#xD;
          -  Patients with viral conjunctivitis or any other infectious disease.&#xD;
&#xD;
          -  Patients with skin lesions on the neck or forehead&#xD;
&#xD;
          -  Patients at high risk of damage from optical radiation, such as aphakic patients, or&#xD;
             patients with decreased sensitivity to light due to fundus disease.&#xD;
&#xD;
          -  Participant unable to be followed throughout the study&#xD;
&#xD;
          -  Advanced cataract or severe opacities in the anterior segment of the eye.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel PAQUES</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hayet Serhane</last_name>
    <phone>0140021144</phone>
    <email>hserhane@15-20.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tania Rilcy</last_name>
    <phone>0140021126</phone>
    <email>trilcy@15-20.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Paques, puph</last_name>
      <phone>01 40 02 14 15</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 4, 2020</study_first_submitted>
  <study_first_submitted_qc>November 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Edema</mesh_term>
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Retinal Detachment</mesh_term>
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Retinal Degeneration</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

